Chongqing Genrix Biopharmaceutical Co (SHSE:688443) EV-to-EBITDA : -8.63 (As of Sep. 26, 2024)

Chongqing Genrix Biopharmaceutical Co EV-to-EBITDA Chart

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial									-18.19	-13.61	-17.49	-17.35	-11.98

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA falls into.

Chongqing Genrix Biopharmaceutical Co EV-to-EBITDA Calculation

Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA for today is calculated as:

Chongqing Genrix Biopharmaceutical Co's current Enterprise Value is ¥6,429.25 Mil.
Chongqing Genrix Biopharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-745.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Genrix Biopharmaceutical Co  (SHSE:688443) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Chongqing Genrix Biopharmaceutical Co's PE Ratio (TTM) for today is calculated as:

Chongqing Genrix Biopharmaceutical Co's share price for today is ¥24.10.
Chongqing Genrix Biopharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2.080.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Chongqing Genrix Biopharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co Business Description